The National ALS Registry has updated its prevalence estimates for amyotrophic lateral sclerosis (ALS) in the U.S. for 2012 and 2013, providing critical data for advocacy and research efforts. This report highlights the ongoing need for awareness and resources for ALS patients.
The Agency for Toxic Substances and Disease Registry's (ATSDR) National ALS Registry today released its second report on the prevalence of amyotrophic lateral sclerosis (ALS, commonly known as Lou Gehrig's disease) in the United States for the years 2012 and 2013.
Original title: “National ALS Registry Releases Updated Prevalence Estimates - Press Release”